Abstract
Older adults with advanced cognitive impairment have a limited life expectancy and the use of multiple drugs is of questionable benefit in this population. The aim of the present study was to assess if, in a sample of nursing home (NH) residents with advanced cognitive impairment, the effect of polypharmacy on mortality differs depending on estimated life expectancy.
| Lingua originale | Inglese |
|---|---|
| pagine (da-a) | 450.e7-450.e7-12 |
| Rivista | Journal of the American Medical Directors Association |
| Volume | 14 |
| Numero di pubblicazione | 6 |
| DOI | |
| Stato di pubblicazione | Pubblicato - 2013 |
All Science Journal Classification (ASJC) codes
- Infermieristica Generale
- Politiche della Salute
- Geriatria e Gerontologia
Keywords
- 80 and over
- Adrenergic beta-Antagonists
- Aged
- Anti-Bacterial Agents
- Benzodiazepines
- Cardiotonic Agents
- Cognition Disorders
- Digoxin
- Drug Utilization
- European Union
- Female
- Humans
- Hydroxymethylglutaryl-CoA Reductase Inhibitors
- Israel
- Life Expectancy
- Male
- Nursing Homes
- Polypharmacy